15%/0.9%, 0.4 ml spot-on for dogs 1.5-7 kg
Assessed clinical scopeDog · Labelled monthly topical control of fleas and ticks in dogs within the exact presentation weight band · On the skin
Care settingVeterinary-selected home spot-on use after parasite and patient assessment, with response review when infestation persists
vetman score
4.9/10
Weak evidence support
Evidence confidence: Low
Georgia: Yes, veterinary · № 235-11 · Verified on 22 Oct 2026
A locally registered dog-only spot-on with convenient monthly use, but no independent exact-product efficacy study or transparent public dossier. It is a weak-evidence option that should be used only in the exact weight band, with response reassessment and strict protection of cats from direct or wet-coat exposure.
Regulatory and scientific credibility5.5/10
The exact presentation is actively registered in Georgia and current manufacturer material verifies the formulation, weight band and monthly label. However, no regulator-hosted SPC, EMA/FDA-style public assessment or transparent full dossier for this exact dinotefuran/flumethrin spot-on was found.
Clinical efficacy3.5/10
The manufacturer claims 30-day flea and tick protection, but no independent controlled study of this exact 15% dinotefuran plus 0.9% flumethrin spot-on was found. Studies and guidelines support the individual actives or different collars and combinations; they do not validate this formulation, dose distribution or every claim.
Safety and tolerability4.5/10
Dog tolerability data for the exact formulation and repeated use are not publicly available. Pyrethroids generally have a wider margin in dogs than cats, but local and neurologic reactions and ingestion remain possible; a retrospective feline toxicosis series specifically included two Soltif exposures, making species separation essential.
Clinical practicality7.0/10
A whole monthly weight-banded pipette is simple to apply. Correct weight selection, direct placement on dry intact skin where the dog cannot lick, separation from other animals until dry and the 72-hour bathing restriction remain meaningful adherence requirements.
Full-course cost-effectiveness-
Price was not assessed and is excluded from the overall score.
Important safety and use flags
- Dog-only product: never apply to a cat. Keep cats from grooming or contacting the treated dog until the application site is completely dry; Soltif exposure has been recorded in hospitalised feline pyrethroid-toxicosis cases.
- Do not use in puppies younger than 8 weeks or in an animal with known hypersensitivity to an ingredient.
- Weigh the dog and use only the presentation matching its labelled weight band; boundary weights require deliberate selection rather than estimation.
- Apply the entire pipette directly to dry intact skin between the shoulder blades where the dog cannot lick. Separate treated animals until dry.
- Monitor for local irritation, salivation, vomiting, depression, ataxia, tremor, twitching or seizures. If exposure or neurologic signs occur, prevent further licking, wash off when appropriate and seek urgent veterinary advice.
- Do not layer with another flea/tick pesticide unless a veterinarian has reviewed the active ingredients, intervals and cumulative neurotoxicity.
- Do not bathe or shampoo the dog for 72 hours after application. Frequent water exposure may reduce topical persistence; reassess rather than shortening the interval without evidence.
- No independent controlled trial of the exact 15% dinotefuran plus 0.9% flumethrin spot-on was found. Ingredient and other-formulation studies cannot establish this product’s full 30-day performance.
- Ectoparasiticides may harm aquatic organisms. Prevent the product, empty pipette and recently treated dog from contaminating surface water; dispose of packaging responsibly.
Assessment sources+
